224 related articles for article (PubMed ID: 5998855)
1. [Research on skin temperature and internal temperature in subjects with obliterating arteriopathy. Action of the association of kallikrein and meso-inositol hexanicotinate].
Blasi A; Licciardello M
Clin Ter; 1966 Oct; 39(1):33-8. PubMed ID: 5998855
[No Abstract] [Full Text] [Related]
2. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
Blasi A; Licciardello M
Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
[No Abstract] [Full Text] [Related]
3. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy].
D'Ayala Valva G
Recenti Prog Med; 1966 Jun; 40(6):XIX-XXXVI. PubMed ID: 6014405
[No Abstract] [Full Text] [Related]
4. [Contribution to the study of internal temperatures in subjects with arterial diseases with obliterating evolution. I. Effects of sodium nicotinate, theophylline-ethylenediamine and theophylline nicotinate].
Blasi A; Licciardello M
Boll Soc Ital Cardiol; 1966; 11(4):1111-5. PubMed ID: 5992024
[No Abstract] [Full Text] [Related]
5. [Contribution to the study of internal temperatures in subjects with arterial diseases with obliterating evolution. II. Effects of venous administration of papaverine hydrochloride].
Blasi A; Licciardello M
Boll Soc Ital Cardiol; 1966; 11(4):1116-9. PubMed ID: 5992025
[No Abstract] [Full Text] [Related]
6. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
Cascio F
Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
[No Abstract] [Full Text] [Related]
7. [Medical therapy of obliterating arteriopathies].
Schwarz D
Minerva Med; 1969 Oct; 60(87):4335-44. PubMed ID: 4242895
[No Abstract] [Full Text] [Related]
8. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
Tardito E; Azzolini A; De Cristofaro A; Papacharalambus D
Minerva Cardioangiol; 1972; 20(7):369-89. PubMed ID: 5050745
[No Abstract] [Full Text] [Related]
9. [Effect of bencyclane in obliterative arterial diseases].
Kusztos D
Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658
[No Abstract] [Full Text] [Related]
10. [Therapy of peripheral circulatory disorders using BAY b 7979, demonstrated through Tc-99m muscular clearance].
Nedjabat T; Ebinger H; Birtel FJ
Med Welt; 1976 Aug; 27(34):1585-7. PubMed ID: 948260
[No Abstract] [Full Text] [Related]
11. [Inositol hexanicotinate and its cholesteropenic effect].
Crotte Zamora A; Romo López O
Prensa Med Mex; 1974; 39(5-6):287-93. PubMed ID: 4612506
[No Abstract] [Full Text] [Related]
12. [Ocular changes experimentally induced in guinea pigs treated with an association of kallikrein and meso-inositol hexanicotinate].
Ronchieri M
Atti Accad Fisiocrit Siena Med Fis; 1968; 17(1):544-54. PubMed ID: 5761261
[No Abstract] [Full Text] [Related]
13. [Combined drug therapy of arterial circulation disorders].
Grözinger KH
Med Welt; 1980 Jul; 31(27):1015-8. PubMed ID: 6903251
[No Abstract] [Full Text] [Related]
14. [On the fibrinolytic effect of the combination of kallikrein with meso-inositol hexanicotinate].
Zedda S
Clin Ter; 1967 Sep; 42(6):509-24. PubMed ID: 5617888
[No Abstract] [Full Text] [Related]
15. [Comparative studies of the response of normolipemic and dyslipemic aged subjects to 2 forms of delayed-action nicotinic acid polyesters. Pentaerythrotol tetranicotinate and inositol hexanicotinate. Results of a controlled cross-over trial].
Ziliotto GR; Lamberti G; Wagner A; Cima L; Genco G
Arch Sci Med (Torino); 1977; 134(4):359-94. PubMed ID: 345998
[TBL] [Abstract][Full Text] [Related]
16. [Our experience with lumbar gangliectomy in treatment of chronic peripheral obliterating arteriopathy of the lower extremities].
Longhino C; Postiglione G; Portis PA
Osp Ital Chir; 1968; 19(4):375-94. PubMed ID: 5718566
[No Abstract] [Full Text] [Related]
17. [Treatment of hyperlipemia and steatosis by high doses of meso-insitol hexanicotinate].
Neuman M; Cachin M; Galian P; Charbonnier A; Pergola F
Sem Ther; 1968 Dec; 44(10):660-3. PubMed ID: 5706294
[No Abstract] [Full Text] [Related]
18. [Acute effect of xanthinol nicotinate on cutaneous and intramuscular temperature in diabetic patients].
Berezovsky MR; Berstein S; Lopez Morillas AM; Novoa FC; Acuña E; Reitich GE; Gottlieb S
Prensa Med Argent; 1971 Jul; 58(18):923-31. PubMed ID: 5095397
[No Abstract] [Full Text] [Related]
19. [State of the kallikrein-kinin system of the blood and lipid metabolism in patients with obliterating atherosclerosis associated with diabetes mellitus].
Pokrasen NM; Kobets LG; Il'chuk OS
Klin Khir (1962); 1983 Jul; (7):72-3. PubMed ID: 6555416
[No Abstract] [Full Text] [Related]
20. [Experiences with the treatment of peripheral vascular diseases with Xavin].
Brücknerová O
Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
[No Abstract] [Full Text] [Related]
[Next] [New Search]
